ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The Philippines Has Approved ReCOV For Phase II/III Cinical Trial
January 17, 2022The Philippines has approved Recombinant Two-Component COVID-19 Vaccine (ReCOV) developed by Jiangsu Recbio Technology Co., Ltd. ("Recbio") for Phase II/III clinical research. -
Recbio Receives Pharmaceutical Production License from Jiangsu Medical Products Administration for Production of COVID-19 Vaccine
November 17, 2021Jiangsu Recbio Technology Co., Ltd. ("Recbio"), a biopharmaceutical company focusing on the research, development and commercialization of innovative vaccines that can address prevalent diseases...
Pharma Sources Insight January 2025
